DSM Venturing is the corporate venture capital arm of Royal DSM, focusing its investments on innovative companies in the health, nutrition, and materials sectors. Their strategy involves supporting startups that align with DSM's strategic objectives, aiming to drive growth and sustainability, typically investing in seed, Series A, and Series B funding rounds.
33% of their portfolio is in Food & Agriculture. Their most common stage is series-a (50% of deals). Average disclosed round size is $12.1M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
$60M
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| MMeatable | Series B | $35M | Aug 2023 |
| PPaleo | Series A | $12.7M | Feb 2023 |
| MMeala | Pre-Seed | $1.9M | Feb 2023 |
 Chinova Bioworks | Series A | $6M | Jun 2022 |
| OOK Capsule | Seed | $9.5M | Mar 2022 |
| LLeading Edge Equipment | Series A | $7.6M | Oct 2020 |
Top Co-Investors
Agronomics1 shared
Invest-NL1 shared
BlueYard Capital1 shared
Prime Impact Fund1 shared
Clean Energy Ventures1 shared
Rich Products Ventures1 shared
Mucker Capital1 shared
Next Capital1 shared
Planet A1 shared
Gimv1 shared
Siddhi Capital1 shared
Last updated: 18 March 2026